期刊文献+

多学科协作治疗T_4N_(1c)M_1期结肠癌一例

原文传递
导出
摘要 一、病例介绍   女性患者,55岁。主诉:因“体检发现肝多发占位1周”于2011年10月至我院就诊。该患者既往体健,否认肝炎、高血压及心脏病等慢性病史,否认家族性遗传病史。婚育史:已婚,育1子。体检:PS评分0分,浅表淋巴结无肿大,腹部查体未发现明显阳性体征。辅助检查:血常规、肝肾功能无明显异常,乙肝表面抗原阴(-),肿瘤标志物:CEA 为781.4 ng/ml,AFP为1.5 ng/ml,CA19-9为287 ng/ml。腹部CT、MRI和PET/CT检查示:结肠局部肠壁增厚,肠周多发性小淋巴结,肝内多发性低密度灶。结肠镜检查示:距肛缘35 cm处占位,肿物占肠腔一周,内镜不能通过,活检病理示:腺癌。基因检测为K-ras和B-raf基因均为野生型。
出处 《中华结直肠疾病电子杂志》 2014年第1期42-43,共2页 Chinese Journal of Colorectal Diseases(Electronic Edition)
  • 相关文献

参考文献8

  • 1Ye Le-Chi,Liu Tian-Shu,Ren Li. Randomized Controlled Trial of Cetuximab Plus Chemotherapy for Patients With KRAS Wild-Type Unresectable Colorectal Liver-Limited Metastases[J].Journal of Clinical Oncology,.
  • 2Bokemeyer C,Bondarenko I,Hartmann JT. Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer:the OPUS study[J].ANNALS OF ONCOLOGY,2011,(07):1535-1546.
  • 3Van Cutsem E,Bajetta E,Valle J. Cetuximab Plus Irinotecan,Fluorouracil, and Leucovorin.AsFirst-Line Treatment for Metastatic Colorectal Cancer:Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status[J].Journal of Clinical Oncology,2011,(15):2011-2019.
  • 4Xu J,Qin X,Wang J. Chinese guidelines for the diagnosis and comprehensive treatment of hepatic metastasis of colorectal cancer[J].Journal of Cancer Research and Clinical Oncology,2011,(09):1379-1396.
  • 5Buell JF,Thomas MT,Rudich S. McMasters KM(2008) Experience with more than 500 minimally invasive hepatic procedures[J].ANNALS OF SURGERY,.
  • 6Simillis C,Constantinides VA,Tekkis PP. Laparoscopic versus open hepatic resections for benign and malignant neoplasms-a meta-analysis[J].SURGERY,2007,(02):203-211.
  • 7秦新裕;许剑民.结直肠癌肝转移的早期诊断和综合治疗[M]北京:人民卫生出版社,2010.
  • 8Dexiang Z,Li R,Ye W. Outcome of patients with colorectal liver metastasis:analysis of 1,613 consecutive cases[J].ANNALS OF SURGICAL ONCOLOGY,2012,(09):2860-2868.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部